CVS Health (previously CVS Corporation and CVS Caremark Corporation) is an American healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; Aetna, a health insurance provider, among many other brands. The company's headquarters is in Woonsocket, Rhode Island.
| Revenue (TTM) | $412.64B |
| Gross Profit (TTM) | $56.30B |
| EBITDA | $16.68B |
| Operating Margin | 3.86% |
| Return on Equity | 6.21% |
| Return on Assets | 2.97% |
| Revenue/Share (TTM) | $324.15 |
| Book Value | $62.37 |
| Price-to-Book | 1.45 |
| Price-to-Sales (TTM) | 0.28 |
| EV/Revenue | 0.428 |
| EV/EBITDA | 13.26 |
| Quarterly Earnings Growth (YoY) | 188.80% |
| Quarterly Revenue Growth (YoY) | 7.10% |
| Shares Outstanding | $1.28B |
| Float | $1.28B |
| % Insiders | 0.06% |
| % Institutions | 90.84% |
Volatility is currently expanding
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
CVS Health (CVS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
CVS Pharmacy® and MinuteClinic® offer MMR vaccinations to help protect eligible patients and communities WOONSOCKET, R.I., Sept. 23, 2026 /PRNewswire/ -- Following the Tennessee Department of Health's recent confirmation of nine measles cases in the state, CVS Health® (NYSE:CVS) is reminding Tennesseans that the measles-mumps-rubella (MMR) vaccine is available at CVS Pharmacy® and MinuteClinic® locations statewide for eligible patients.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
CVS Health and Cardinal Health are benefiting from healthcare growth, but differences in performance, valuation and targets shape the outlook.
CVS Health (CVS) concluded the recent trading session at $87.6, signifying a -1.4% move from its prior day's close.
CVS raises its 2026 revenue and earnings outlook, but reimbursement pressure, macro headwinds and soft front-store demand could weigh on results.
Oncology bundling to support all eligible Medicaid members for all cancer types Full roll-out across all Aetna businesses in 2027 HARTFORD, Conn., Sept. 17, 2026 /PRNewswire/ -- Aetna®, a CVS Health® company (NYSE: CVS), is expanding prior authorization bundles across all cancer types for members in eligible1 Medicaid states as of September 1, with plans to expand across all lines of business in 2027.
CVS trades at a forward multiple that screams cheap, yet the street's already bullish and our model runs even hotter. Before you trust either read, there are a few risks that could turn this setup into a trap.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on CVS and any ticker you trade — then tracks every position and per-strategy win rate.
